Oxford Immunotec Announces Preliminary Revenue for Fourth Quarter and Full Year 2017
January 08, 2018 08:30 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that based on...
Oxford Immunotec to Present at the 36th Annual J.P. Morgan Healthcare Conference
January 03, 2018 09:25 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter...
Oxford Immunotec and QIAGEN N.V. Settle Patent Infringement Lawsuit
December 15, 2017 16:04 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Ltd. (Nasdaq:OXFD) and QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt Stock Exchange:QIA) announced today that...
Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference
November 21, 2017 09:15 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec to Present at the Jefferies 2017 London Healthcare Conference
November 10, 2017 09:00 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec Reports Third Quarter 2017 Financial Results
October 31, 2017 07:00 ET
|
Oxford Immunotec Global PLC
Third quarter revenue of $30.4 million, an increase of 17% compared to prior year periodContinued growth from both the Tuberculosis (TB) and Tick-borne disease franchises, with double-digit revenue...
Oxford Immunotec Schedules Third Quarter 2017 Earnings Release and Conference Call for October 31, 2017
October 17, 2017 09:15 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing...
Oxford Immunotec Announces Update in Patent Infringement Litigation
September 27, 2017 09:25 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec to Present at the Baird 2017 Global Healthcare Conference
August 30, 2017 16:15 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec Appoints Stefan Linn as Chief Operating Officer
August 30, 2017 09:00 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...